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FROM JULY 1994 through July 1996, 73 pancreas transplants were performed at the University of Pitts-
burgh. To avoid the high complication rate related to 
bladder drainage! and to reduce the rate of reoperation, 
enteric drainage according to the technique described by 
Starzl,2 was performed in the majority of patients. Rejec-
tion episodes were documented with fine needle aspiration 
(FNA) of the pancreas and/or kidney? 
MATERIALS AND RESULTS 
Sixty-three Type I diabetic patients received simultaneous pancreas 
kidney transplants (SPK). and 10 received solitary pancreas trans-
plants. 
Immunosuppression included tacrolimus 0.15 mg/kg/po preop-
eratively and intravenous tacrolimus 0.05 mglkg for 5 to 7 days 
postoperatively to achieve target levels of 20 to 30 ng/mL during 
the first week. Following this. oral tacrolimus was given every 12 
hours to achieve blood levels of 20-25 ng/mL from 1 to 2 weeks. 15 
to 20 ng/mL from 2 to 4 weeks. 10 to 15 ng/mL from 1 to 3 months. 
and 5-12 ng/mL by 6 months. Azathioprine was given at an initial 
dose of 5 mglkg and 1.5 to 2.0 mglkg postoperatively thereafter. An 
intravenous bolus of methylprednisolone was given intraoperatively 
and tapered from 200 mg to 20 mg over 5 days. The last 20 patients 
received mycophenolate mofetil instead of azathioprine. 
CMV prophylaxis was not used except in the seropositive to 
seronegative donor recipient combinations. Only one patient de-
veloped clinically significant CMV disease. which lasted a week. 
Complications of 18 bladder drained pancreases (50%) included 
reflux pancreatitis in 3 eventually leading to graft loss in 2. 
hematuria requiring transfusion in 3. fistula in 2 requiring conver-
sion to enteric drainage in 1. and severe acidosis requiring hospi-
talization in 3 with conversion to enteric drainage in 1. 
Complications of 55 enteric drained pancreases (13%) included 
anastomotic perforation in 1 repaired by simple closure and 
peritoneal lavage. suture line bleeding requiring transfusion in 3. 1 
splenic artery anastomotic fistula with graft loss and deep wound 
abscess in 2. 
One patient lost both pancreas and kidney from antibody-
mediated rejection 5 days postoperatively in a patient who was 
highly sensitized and developed a positive cytotoxic crossmatch 3 
days after transplantation. Another enteric drained patient rejected 
both organs following severe systemic and wound candida infection 
necessitating discontinuation of immunosuppression. A third kid-
ney was lost from thrombosis at 3 weeks. Six patients lost pan-
creases within the first week from donor related factors. 
0041-1315/97/$17.00 
PI! S0041-1345(96)00375-2 
642 
Patient survival was 99% (1 recipient died of a brain stem 
infarction 7 months following removal of a solitary pan-
creas transplant at 3 months from recurrent reflux pancreatitis). 
Kidney and pancreas survival was 95% and 85%, respectively 
(median follow-up 1 year). 
DISCUSSION AND CONCLUSIONS 
The majority of the enteric drained patients were dis-
charged between 1 and 2 weeks and had a significantly 
lower surgical complication rate. The single anastomotic 
perforation was noted in a patient who had been on steroids 
for almost a year following a successful kidney transplant 
(both grafts have normal function). In both the enteric and 
bladder drained patients, suture line bleeding (3 in each 
group) stopped spontaneously and did not extend hospital-
ization in spite of the transfusion requirement. Careful 
donor selection and the rapid en bloc recovery technique 
employed in the last year and a half have eliminated early 
graft failure.4 
In conclusion, only 2 grafts were lost from rejection, a 
significantly reduced morbidity was noted in the enteric 
drained group, and severe CMV disease was noted in only 
1 patient who had a febrile illness for 1 week which 
resolved. The low incidence of CMV disease may have been 
related to not using antibody induction therapy, which did 
not appear to be necessary in the tacrolimus treated pan-
creas recipients. 
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